Biotech by one-year price change

How far the share price has moved over the last 52 weeks.

Moderna leads the 24 biotech ranked by one-year price change, at +755%, ahead of Kodiak Sciences (+396%) and Twist Bioscience (+340%). Figures as of 18 Nov 2026, 14:39 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
Moderna+755%
Median
+40.0%
Combined market value
TRY 42.61T
Countries
5

Market values as of .

Biotech by one-year price change
#Company1 year ↓Market capPriceToday1 yearPrice, 30 daysCountry
1ModernaMRNA · Health Care+755%TRY 4.2TTRY 10,375.17 0.38% down 755% up United States
2Kodiak SciencesKOD · Health Care+396%TRY 320.7BTRY 4,904.06 0.60% up 396% up United States
3Twist BioscienceTWST · Health Care+340%TRY 380.4BTRY 5,579.13 1.08% down 340% up United States
4ImmunityBioIBRX · Health Care+193%TRY 332.2BTRY 312.31 0.93% down 193% up United States
5Revolution MedicinesRVMD · Health Care+131%TRY 1.76TTRY 8,143.72 0.60% down 131% up United States
6Adaptive BiotechnologiesADPT · Health Care+88.1%TRY 233BTRY 1,439.29 0.32% up 88% up United States
7Kymera TherapeuticsKYMR · Health Care+87.5%TRY 525.2BTRY 6,152.48 0.53% up 87% up United States
8CG OncologyCGON · Health Care+85.3%TRY 358.6BTRY 4,014.40 0.98% up 85% up United States
9ExelixisEXEL · Health Care+62.6%TRY 845.9BTRY 3,466.53 0.49% up 63% up United States
10BiogenBIIB · Health Care+49.3%TRY 1.87TTRY 12,661.51 0.25% up 49% up United States
11Krystal BiotechKRYS · Health Care+46.3%TRY 450.8BTRY 15,212.75 1.18% up 46% up United States
12ImmunovantIMVT · Health Care+43.4%TRY 349.8BTRY 1,690.08 1.05% up 43% up United States
13Halozyme TherapeuticsHALO · Health Care+36.6%TRY 551BTRY 4,833.30 0.01% up 37% up United States
14AmgenAMGN · Health Care+33.7%TRY 12.32TTRY 22,772.79 1.25% down 34% up United States
15Gilead SciencesGILD · Health Care+32.9%TRY 10.58TTRY 8,525.95 0.56% down 33% up United States
16Bio-TechneTECH · Health Care+25.6%TRY 575.3BTRY 3,662.18 0.12% up 26% up United States
17VaxcytePCVX · Health Care+22.2%TRY 472.2BTRY 2,982.82 0.29% down 22% up United States
18Neurocrine BiosciencesNBIX · Health Care+20.2%TRY 844.3BTRY 8,341.63 0.17% down 20% up United States
19Scholar Rock HoldingSRRK · Health Care+13.6%TRY 289.2BTRY 2,370.04 4.40% up 14% up United States
20QiagenQGEN · Health Care+12.0%TRY 517BTRY 2,503.60 0.07% down 12% up Netherlands
21RepligenRGEN · Health Care+4.58%TRY 544.2BTRY 8,512.85 4.23% up 5% up United States
22argenxARGX · Health Care+3.60%TRY 3.04TTRY 48,265.02 1.15% up 4% up Belgium
23BioNTechBNTX · Health Care-16.3%TRY 1.06TTRY 4,274.56 0.02% up 16% down Germany
24CRISPR TherapeuticsCRSP · Health Care-20.9%TRY 205.4BTRY 2,117.89 4.74% up 21% down Switzerland

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 50.3600 TRY).

Questions and answers

Which biotech rank first by one-year price change?

Moderna (+755%), Kodiak Sciences (+396%) and Twist Bioscience (+340%) are the top three of the 24 biotech ranked by one-year price change as of 18 Nov 2026, 14:39 UTC.

How many biotech are in this ranking?

24 are ranked by one-year price change.

What are these biotech worth together?

The 24 biotech ranked by one-year price change have a combined market value of TRY 42.61T as of 18 Nov 2026, 14:39 UTC.

What does ranking by one-year price change measure?

How far the share price has moved over the last 52 weeks.

Cite this page

Funkfolio, “Biotech by one-year price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=year-change

Underlying data: Yahoo Finance; SEC EDGAR.